D E V

4.2K posts

D E V banner
D E V

D E V

@devwowpeace

Give Away Account || @/jayardevorn12_ 🍣 || 4 devices 📱 📱 📱📱 || Not Multi

Katılım Ağustos 2025
1.2K Takip Edilen545 Takipçiler
Sabitlenmiş Tweet
D E V
D E V@devwowpeace·
Thank you for this @ax1vc for this opportunity wish me luck! 🍀 🫶🏻💙 For me one of the biopharma theme I wish investors tracked more clearly is the growing role of AI in drug discovery, especially companies combining biotech with machine learning. And also about catalysts like faster clinical trial design, predictive diagnostics, and personalized medicine that could reshape the industry, but i think many investors still underestimate how impactful this shift and may become over the next few years. Question: Do you think the future of biopharma investing will favor investors who understand the science deeply, or investors who have the best AI tools to interpret and contextualize the data faster?
D E V tweet mediaD E V tweet mediaD E V tweet media
English
5
4
15
174
D E V
D E V@devwowpeace·
@blankcode_x Di makatulog, kase first space ko toh na sinalihan ko sayo kuys 🫶🏻, kaya dapat tapusin HAHAHAHA
Filipino
1
0
1
67
D E V
D E V@devwowpeace·
@blankcode_x sakto sa pfp ko ah blue and yellow , grabee hahaha 😆
Filipino
0
0
0
78
D E V
D E V@devwowpeace·
Goodnight everyone, need to rest na, lets get a win tomorrow, thank you papa GOD for today’s blessing 🙏🏻🫶🏻💙
English
0
0
12
139
D E V retweetledi
︎Bang || Garr
︎Bang || Garr@Bang_Garrx·
After 15 hours, I’ll reward one selected entry with 10 usdt. Re-post and foIIow the sponsor @grwmolly. [BG 534]
English
284
2K
304
11.5K
D E V retweetledi
︎Bang || Garr
︎Bang || Garr@Bang_Garrx·
In 15 hours, I’ll finalize one winner for 10 usdt. Re-post and foIIow the sponsor @jiv4na. [BG 536]
English
124
842
160
5K
D E V
D E V@devwowpeace·
@MrBsol @nexocooker 99EvJskui7m178TTJHYisDLk786Mx2HddLbCHvQZmb7f MR B SOL NOTICE ME 🍀 MR B SOL NOTICE ME 🍀 MR B SOL NOTICE ME 🍀 MR B SOL NOTICE ME 🍀 MR B SOL NOTICE ME 🍀 MR B SOL NOTICE ME 🍀
D E V tweet media
English
0
0
1
132
D E V
D E V@devwowpeace·
11:11 WITH GOD ALL THINGS ARE POSSIBLE 🍀 🙏🏻💙🫶🏻
English
0
1
6
119
D E V
D E V@devwowpeace·
@vveefo Di you see me @vveefo ? If yes can i get a first win from you? 99EvJskui7m178TTJHYisDLk786Mx2HddLbCHvQZmb7f
GIF
English
0
0
0
22
D E V
D E V@devwowpeace·
Thank you for this @ax1vc for this opportunity wish me luck! 🍀 🫶🏻💙 For me one of the biopharma theme I wish investors tracked more clearly is the growing role of AI in drug discovery, especially companies combining biotech with machine learning. And also about catalysts like faster clinical trial design, predictive diagnostics, and personalized medicine that could reshape the industry, but i think many investors still underestimate how impactful this shift and may become over the next few years. Question: Do you think the future of biopharma investing will favor investors who understand the science deeply, or investors who have the best AI tools to interpret and contextualize the data faster?
D E V tweet mediaD E V tweet mediaD E V tweet media
English
5
4
15
174
D E V retweetledi
AX1
AX1@ax1vc·
Giveaway for our upcoming X Space with Lucent. $1,000 USDC for 10 winners - $100 each. To enter: • like • repost • follow @UseLucentHQ • reply with one biopharma theme, catalyst, or company you wish investors could track more clearly GLP-1s, oncology, rare disease, gene therapy, longevity, radiopharma, AI drug discovery, FDA catalysts - all fair. Lucent is building AI-native biopharma intelligence for one of the hardest markets to read. Bring a sharp question before the Space. Winners will be contacted within 7 days after the Space.
English
174
176
240
5.9K
D E V retweetledi
AX1
AX1@ax1vc·
X Space - Thursday, May 28, 5PM UTC AX1 is partnering with @UseLucentHQ Lucent is an Alliance alum building in one of the harder corners of investing: biopharma. Join us with @JulianMalinak, co-founder of Lucent, to discuss why biopharma may need a much better investing interface. This market moves on FDA decisions, trial readouts, filings, expert debates, and small signals most investors never learn how to read. A lot of the information is technically public, but public does not mean understandable. It is scattered and hard to turn into a view before the market already reacts. Lucent is building for that gap. AI-native biopharma intelligence that helps investors track catalysts, understand company and asset-level context, and see why a signal may matter. Set a reminder. x.com/i/spaces/1DGle…
English
55
115
185
3.7K
D E V
D E V@devwowpeace·
po*
QST
0
0
0
29
D E V
D E V@devwowpeace·
sana may humabol na win tonight papa GOD 🙏🏻🫶🏻💙
Filipino
1
0
8
172